Suzanne Morgan
Director, Market Access Strategy & Marketing, National Accounts & Patient Services Stealth BioTherapeutics
Seminars
Thursday 16th July 2026
FDA approval: Now What?
3:30 pm
- Defining strategies for EAP patients that are now ready to be transferred to commercial products
